Understanding Barriers to Initiation and Adherence to Endocrine Therapy in Young Breast Cancer Survivors of Diverse Backgrounds

Inclusion Criteria: * Are Hispanic, Latina, Black, or identify as socio-economically disadvantaged (any racial/ethnic background) as measured by an item of financial distress answering that they are "having difficulty paying the bills no matter what they do" to a question about their current household financial situation.18, 19 * report a history of Stage 1-3 breast cancer * reports HR+ breast cancer and confirm that they have had a discussion with their doctor about adjuvant ET; OR indicate that they are taking ET, even if they do not know their HR status, answer they are HR-, or do not recall having a discussion about ET) * not in active treatment (e.g., chemotherapy, radiation), with the exception of Herceptin * at least 3 months, but no more than 3 years out of completion of active treatment * no evidence of recurrent/metastatic disease * at least 18, but\< 45 years of age at diagnosis of first invasive breast cancer * English or Spanish speaking * are willing to consent to the interview Exclusion Criteria: * HR- breast cancer and indicate they are not taking ET * HR+ breast cancer but do not confirm discussion of ET or indicate they are taking ET * Stage 0 (DCIS) breast cancer * Recurrent or metastatic disease * Less than 3 months or more than 3 years post-active treatment * Less than 18 years old or ≥45 years old at diagnosis